{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:17:45Z","timestamp":1787894265540,"version":"build-2784847793"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>CircZNF609 (hsa_circ_0000615), a back-spliced transcript derived from the ZNF609 gene locus, has garnered increasing attention for its functional roles in tumor progression across multiple cancer types. However, no pan-cancer meta-analysis has systematically evaluated its prognostic value and association with clinicopathological aggressiveness. We therefore performed this systematic review and meta-analysis to synthesize all available clinical evidence addressing this critical gap.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically retrieved literature from five databases (PubMed, Web of Science, Embase, the Cochrane Library and CNKI) up to April 2, 2026. Hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs) were synthesized to quantify the link between circZNF609 levels and overall survival (OS) or clinicopathological variables. Heterogeneity assessment, sensitivity analysis, and publication bias evaluation were also performed. Additionally, a circZNF609-mediated ceRNA network was reconstructed based on experimentally validated targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 12 studies involving 791 patients were included in this meta-analysis. Elevated circZNF609 expression was significantly associated with worse overall survival (HR\u00a0=\u00a02.31, 95% CI:1.74-3.07,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001; I\u00b2 = 55.2%). Additionally, high circZNF609 expression was correlated with advanced TNM stage (OR\u00a0=\u00a02.34, 95% CI: 1.68-3.27,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001) and increased risk of lymph node metastasis (OR\u00a0=\u00a05.28, 95% CI: 3.48-8.00,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001). No significant associations were found between circZNF609 expression and age, sex, tumor size, or histological differentiation. Sensitivity analyses confirmed the robustness of the pooled results, and Begg\u2019s test (\n                      <jats:italic>P<\/jats:italic>\n                      =\u00a00.493) and Egger\u2019s regression test (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.197) indicated no significant publication bias. Mechanistically, the reconstructed ceRNA network suggested that circZNF609 may exert oncogenic effects via cell-cycle and metastasis-related pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Increased circZNF609 expression is associated with adverse survival outcomes and aggressive clinicopathological behavior across multiple malignancies. The ceRNA network offers mechanistic support for these clinical associations. CircZNF609 warrants validation in prospective, multi-ethnic cohorts as a promising prognostic biomarker and candidate therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1933818","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:30:30Z","timestamp":1787891430000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CircZNF609 as a potential prognostic biomarker across multiple cancers: a systematic review and meta-analysis with ceRNA network exploration"],"prefix":"10.3389","volume":"16","author":[{"given":"Menglan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Tu","sequence":"additional","affiliation":[{"name":"College of First Clinical Medicine, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangnian","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine","place":["Nanjing, Jiangsu, China"]},{"name":"College of First Clinical Medicine, Nanjing University of Chinese Medicine","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.837343","article-title":"Emerging roles of circ-ZNF609 in multiple human diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.cd-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0243-y","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Chen","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: Characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.12.021","article-title":"The landscape of circular RNA in cancer","volume":"176","author":"Vo","year":"2019","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14218\/erhm.2024.00042","article-title":"Prognostic and clinicopathological significance of circPVT1 in solid tumors: A systematic review and meta-analysis","volume":"10","author":"Li","year":"2025","journal-title":"Exploratory Res Hypothesis Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00262-025-04176-z","article-title":"Circular RNAs in cancer: Its biogenesis, functions, relationships with cancer progression, applications in immunotherapy and biomarker potentials","volume":"75","author":"Gao","year":"2026","journal-title":"Cancer Immunol Immunother"},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/bs.acc.2020.02.008","article-title":"Circular RNAs and cancer: Opportunities and challenges","volume":"99","author":"Sole","year":"2020","journal-title":"Adv Clin Chem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2024.06.001","article-title":"RNA regulatory mechanisms controlling TGF-beta signaling and EMT in cancer","author":"Bracken","year":"2024","journal-title":"Semin Cancer Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/apm.70118","article-title":"Identification of metastasis-associated circRNA-miRNA-mRNA network reveals novel biomarkers and therapy strategies for esophageal cancer","volume":"134","author":"Huang","year":"2026","journal-title":"APMIS"},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","article-title":"Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis","volume":"66","author":"Legnini","year":"2017","journal-title":"Mol Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s174778","article-title":"CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21203\/rs.3.rs-1098785\/v1","article-title":"CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200\/CDC25B pathway","volume":"39","author":"Feng","year":"2023","journal-title":"Cell Biol Toxicol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110861","article-title":"CircZNF609\/miR-324-5p\/voltage-dependent anion channel 1 axis promotes Malignant progression of ovarian cancer cells","volume":"27","author":"Ren","year":"2024","journal-title":"iScience"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s193031","article-title":"circZNF609 promotes the proliferation and migration of gastric cancer by sponging miR-483-3p and regulating CDK6","volume":"12","author":"Wu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-020-03894-5","article-title":"CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p","volume":"476","author":"Liu","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13046-022-02357-7","article-title":"FMRP ligand circZNF609 destabilizes RAC1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma","volume":"41","author":"Shang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.31222\/osf.io\/v7gm2_v1","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s282162","article-title":"CircRNA ZNF609 knockdown represses the development of non-small cell lung cancer via miR-623\/FOXM1 axis","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2034703","article-title":"Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p","volume":"13","author":"Yin","year":"2022","journal-title":"Bioengineered"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2020.191265","article-title":"Three circRNAs function as potential biomarkers for colorectal cancer","volume":"66","author":"Zhang","year":"2020","journal-title":"Clin Lab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2020.200523","article-title":"Five circRNAs serve as potential diagnostic and prognostic biomarkers in lung adenocarcinoma","volume":"67","author":"Li","year":"2021","journal-title":"Clin Lab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7150\/jca.54934","article-title":"Circular RNA ZNF609 promotes the Malignant progression of glioma by regulating miR-1224-3p\/PLK1 signaling","volume":"12","author":"Du","year":"2021","journal-title":"J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203735","article-title":"YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1","volume":"13","author":"Guan","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: Navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/jcp.29481","article-title":"FUS-induced circular RNA ZNF609 promotes tumorigenesis and progression via sponging miR-142-3p in lung cancer","volume":"236","author":"Liu","year":"2021","journal-title":"J Cell Physiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"B34","article-title":"Circ-ZNF609 promotes migration of colorectal cancer by inhibiting Gli1 expression via microRNA-150","volume":"23","author":"Wu","year":"2018","journal-title":"J Buon"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201904_17558","article-title":"CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p","volume":"23","author":"Zhu","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.molcel.2021.11.032","article-title":"Circular RNA ZNF609\/CKAP5 mRNA interaction regulates microtubule dynamics and tumorigenicity","volume":"82","author":"Rossi","year":"2022","journal-title":"Mol Cell"},{"key":"B37","article-title":"Circular RNAs: An emerging landscape in tumor metastasis","volume":"9","author":"Shen","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11215","article-title":"Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs","volume":"7","author":"Zheng","year":"2016","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201643581","article-title":"CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells","volume":"18","author":"Li","year":"2017","journal-title":"EMBO Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112485","article-title":"CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2\/CD36 pathway","volume":"137","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","article-title":"Current and future perspectives of liquid biopsies in genomics-driven oncology","volume":"20","author":"Heitzer","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-96-9428-0_12","article-title":"Circular RNA in exosomes and its clinical significance","volume":"1485","author":"Farahani","year":"2025","journal-title":"Adv Exp Med Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14652","article-title":"Exosome-delivered circSATB2 targets the miR-330-5p\/PEAK1 axis to regulate proliferation, migration and invasion of lung cancer cells","volume":"13","author":"Zhu","year":"2022","journal-title":"Thorac Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152211","article-title":"Embryonic stem cells-derived exosomes enhance retrodifferentiation of retinal Muller cells by delivering BDNF protein to activate Wnt pathway","volume":"227","author":"Gao","year":"2022","journal-title":"Immunobiology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604999","article-title":"Prognostic markers in cancer: The evolution of evidence from single studies to meta-analysis, and beyond","volume":"100","author":"Riley","year":"2009","journal-title":"Br J Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1933818\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:30:43Z","timestamp":1787891443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1933818\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":47,"alternative-id":["10.3389\/fonc.2026.1933818"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1933818","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1933818"}}